Phase I trial of CCX 140 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 21 Sep 2010
At a glance
- Drugs CCX 140 (Primary)
- Indications Multiple sclerosis; Restenosis; Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors ChemoCentryx
- 21 Sep 2010 Results have been presented at the European Association for the Study of Diabetes (EASD), according to a ChemoCentryx media release.
- 21 Sep 2010 Status changed from active, no longer recruiting to completed, according to a ChemoCentryx media release.
- 20 Jun 2008 New trial record.